Subscribe to our Email Alerts
Menu
Home
About Us
Company Overview
Company Values
Board of Directors
Executive Management
Corporate Directory
Products
DAYBUE™ (trofinetide)
Pipeline
Pipeline
Trofinetide
Rett Syndrome
NNZ-2591
Phelan-McDermid Syndrome
Angelman Syndrome
Pitt Hopkins Syndrome
Hypoxic-ischemic encephalopathy
Prader-Willi Syndrome
Science
Science Behind Neuren's Products
Trofinetide Published Studies & Presentations
Rett Syndrome
NNZ-2591Published Studies & Presentations
Phelan-McDermid Syndrome
Pitt Hopkins Syndrome
Angelman Syndrome
Investors
Investor Dashboard
Share Price Information
ASX Announcements
Annual and Interim Reports
Investor Presentations
Corporate Governance
Analyst Coverage
Shareholder Services
News & Media
Media
Contact
Contact Us
Email Alerts
News & Media
Home
>
News & Media
>
Media
Media
Media
Filter by Year:
2025
2024
2023
19-Mar-2025
belldirect interview
19-Mar-2025
Sharecafe and Finance News Network presentation
20-Jan-2025
43rd J.P. Morgan Healthcare Conference Presentation Webcast
13-Nov-2024
Marcus Today On the Couch podcast with Jon Pilcher
25-Oct-2024
ASX CEO Connect
16-Oct-2024
ShareCafe Small Cap Hidden Gems Presentation
8-Nov-2023
ASX article, 8 Nov 2023
20-Oct-2023
Neuren receives Australian Growth Company of the Year Award
26-May-2023
IRSF Physician Panel: Answering Your Questions About Trofinetide
15-May-2023
IRSF Parent Panel: My Trofinetide Clinical Trial Experience
1
2
3
Next
